On Wednesday 13 May 2020, the Global Health Network hosted a webinar entitled ‘REMAP-CAP and Why we need Platform Trials in a Pandemic’. The goal of the webinar was to introduce REMAP-CAP and the concept of adaptive platform trials more broadly, as well as discuss the upsides and challenges of such trials in a pandemic.

15 May 2020

We are inviting European healthcare workers that currently provide hospital care (both COVID-19 related and non-COVID-19-related), to participate in a 10-min online survey.

RECOVER’s Clinical Biological Study team has published a preprint paper identifying several early independent SARS-CoV-2 introductions without local transmission, highlighting the efficacy of the measures taken in France to prevent virus spread from symptomatic cases.

The Epidemiological and Modelling Study team has published a preprint paper on the possible impact of reopening schools after lockdown on COVID-19 epidemic in the region of Île-de-France (Domenico et al. 2020).

The Clinical Biological Study team of RECOVER has carried out a rapid SARS-CoV-2 whole genome sequencing combined with epidemiological studies to inform public health decision making in the Netherlands (Oude Munnink et al. 2020).

The point prevalence audit survey (PPAS) was extended to capture presentation and management of patients with acute respiratory tract infection during the COVID-19 pandemic.

As part of its research response to the COVID-19 pandemic, the EU-funded RECOVER project (Rapid European COVID-19 Emergency Research response) has enrolled the first participants in three of its studies. This is an important milestone to answer crucial questions on COVID-19 and inform healthcare workers and policymakers on optimal care and effective public health measures.

The University of Antwerp has launched Rapid European COVID-19 Emergency Research response (RECOVER), in collaboration with 9 international partners. The launch comes in response to the impact of the novel Coronavirus (COVID-19) epidemic in Europe.